Community Education for Cardiovascular Disease Prevention

Size: px
Start display at page:

Download "Community Education for Cardiovascular Disease Prevention"

Transcription

1 American Journal of Epidemiology Copyright O 996 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 44, No. 4 Printed in U.S. A Community Education for Cardiovascular Disease Prevention Morbidity and Mortality Results from the Minnesota Heart Health Program Russell V. Luepker, Lennart Rastam, ' 2 Peter J. Hannan, David M. Murray, Clifton Gray, William L Baker, Richard Crow, David R. Jacobs, Jr., Phyllis L Pirie, Steven R. Mascioli, ' 3 Maurice B. Mittelmark, ' 4 and Henry Blackburn The Minnesota Heart Health Program was a community trial of cardiovascular disease prevention methods that was conducted from 980 to 990 in three Upper Midwestern communities with three matched comparison communities. A 5- to 6-year intervention program used community-wide and individual health education in an attempt to decrease population risk. A major hypothesis was that the incidence of validated fatal and nonfatal coronary heart disease and stroke in 30- to 4-year-old men and women would decline differentially in the education communities after the health promotion program was introduced. This hypothesis was investigated using mixed-model regression. The intervention effect was modeled as a series of annual departures from a linear secular trend after a 2-year lag from the start of the intervention program. In the education communities, 2,394 cases of coronary heart disease and 8 cases of stroke occurred, with 2,526 and 39 cases, respectively, being seen in the comparison communities. The overall decline in coronary heart disease incidence was.8 percent per year in men (p = 0.03) and 3.6 percent per year in women (p = 0.00). For stroke, there were no significant secular trends. The authors recently published findings showing minimal effects of sustained intervention on risk factor levels. In the current report, there was no evidence of a significant intervention effect on morbidity or mortality, either for coronary heart disease or for stroke. Am J Epidemiol 996;44: cardiovascular diseases; health education; health promotion; morbidity; mortality; primary prevention Atherosclerosis, clinically manifest as coronary heart disease and stroke, is the major cause of death and disability in many Western industrialized societies (, 2). Strong downward trends in heart disease mortality rates have been observed since the late 960s, and even longer for stroke (3,4). The improvements in heart disease mortality are associated with declining population levels of serum cholesterol, blood pressure, and cigarette smoking (5, 6), while for stroke, they are associated with declining blood pressure levels, achieved partly through better detection and treatment of hypertension (). Received for publication August 8, 995, and in final form January 2, 996. Abbreviations: MHHP, Minnesota Heart Health Program; ICD-9, International Classification of Diseases, Ninth Revision. Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN. 2 Current address: Department of Community Medicine, School of Medicine, Lund University, Malmd, Sweden. 3 Current address: American Medical Systems, Minnetonka, MN. 4 Current address: Department of Psychosocial Sciences, School of Psychology, University of Bergen, Bergen, Norway. Reprint requests to Dr. Russell V. Luepker, Division of Epidemiology, School of Public Health, University of Minnesota, 300 South Second Street, Suite 300, Minneapolis, MN A number of community trials designed to enhance these salutary disease trends have been implemented in the United States and Europe, beginning in the early 90s (8-5). Their purpose has been to develop and test interventions designed to decrease the public health burden of cardiovascular disease. A common denominator has been the use of community-wide and individual health education to influence levels of risk factors, mainly by improving eating and activity patterns and reducing smoking. All of these projects have reported mixed results with regard to risk factor changes (8-0, 6-; C. Smith, Health Promotion Wales, personal communication, 994), with more favorable outcomes being seen in the earlier studies (8-0, 6). Only the North Karelia Project has published results for morbidity and mortality (, ) during 0 years of follow-up, reporting a favorable effect of intervention on ischemic heart disease mortality (). The Minnesota Heart Health Program (MHHP) was the largest of the studies completed, and it involved six communities in Minnesota, North Dakota, and South Dakota (2). The MHHP results regarding changes in risk factor levels were recently published (); the 35

2 352 Luepker et al. changes were modest and usually within levels attributable to chance. The present paper is the final report on the main outcomes of the MHHP. It presents the results of the intervention program on morbidity and mortality from coronary heart disease and stroke in intervention communities relative to trends observed in the comparison communities. MATERIALS AND METHODS The Minnesota Heart Health Program The MHHP was a research and demonstration project conducted during the 980s ( ) and intended for primary prevention of coronary heart disease and stroke. The intervention program involved three communities in Minnesota and North Dakota with a total of approximately 0,000 inhabitants (2, ). It operated on both the individual level and the community level and was based on several theories of behavior change (-28). It developed and implemented a number of community-wide intervention approaches, including mass media campaigns (), systematic risk factor screening and education (30), changes in the environment to encourage "hearthealthy" behavior (3), and direct education of young people (), adults, and health professionals (33). The program aimed specifically at lowering population levels of blood cholesterol, blood pressure, and smoking and increasing the level of physical activity. Research design The research design of the MHHP has been described in detail elsewhere (). Briefly, the MHHP was a nonrandomized community trial with three community pairs (table ). For each pair, two communities were selected that were similar in terms of size, structure, and distance from Minneapolis. Within each pair, one community was chosen, not randomized, for intervention and the other for comparison. As figure shows, the intervention program began on November, 98, in, Minnesota. Twenty-two and 28 months later, respectively, it began in Fargo- Moorhead (North Dakota-Minnesota) and in, Minnesota. The program continued for 5-6 years in each community, with a transition of program coordination to local advisory boards toward the end of that period. Study endpoints Population-wide data on first events of definite coronary heart disease and stroke were used for this study, with restriction to men and women aged 30-4 years and resident in one of the six communities at the time of their event. Hospital discharge register codes (International Classification of Diseases, Ninth Revision (ICD-9) (35)) from 39 hospitals in the six communities (one small hospital declined participation) were used to identify candidate events. The candidate events were then validated with medical records by a standard protocol, summarized below. For out-of-hospital coronary heart disease, candidate events were identified from computerized mortality tapes obtained from the three state Departments of Health and then validated. Out-of-hospital stroke deaths, a small fraction of cases in the age group 30-4 years, were not systematically sought and thus were not included in the analyses. As figure shows, surveillance started in 980 or 98 in all cities and continued for 9 years in and, Minnesota; for 0 years in Fargo- Moorhead and in, South Dakota; and for years in and, Minnesota. TABLE. Characteristics of the paired Intervention and comparison communities in the Minnesota Heart Health Program, Characteristic and community pair* Small rural Large rural Fargo/Moorhead Metropolitan suburban Total populatlont 3,809,053 04,63 8,484 8,95 4,83 Population aged 30-4 yaarsf 3,5 9,53 3,35,054 38,948,5 * All communities are located in Minnesota, except Fargo (North Dakota) and (South Dakota), t 980 US Census data. Validation of definite coronary heart disease The diagnosis of definite coronary heart disease included both fatal and nonfatal cases and both inhospital and out-of-hospital events. It comprised four distinct categories: ) definite in-hospital myocardial infarction (fatal or nonfatal); 2) definite out-ofhospital myocardial infarction; 3) sudden cardiac death; and 4) definite fatal out-of-hospital coronary heart disease. Thus, all nonfatal cases were hospital admissions. Definite in-hospital myocardial infarction. The first category was based on abstraction of records for casepatients residing in one of the MHHP communities and discharged alive or dead from one of the participating hospitals with any of the ICD-9 codes or Events were validated on the basis of a

3 Community Education for Cardiovascular Disease Prevention Project Year Calendar Year (Education) Education Program (Comparison) Surveillance(Both Towns) Fargo-Moorhead (Education) J Education Program (Comparison) Surveillance(Both Towns) (Education) Education Program (Comparison) SurveillancefBoth Towns) " Surveillance Data Includ^n Analysis ^ 3 Surveillance Data Excluded From Analysis H ^ " n ( e n s e Educa^ : : i Transittona, Period i : : g l^j H ] C o m m u n i t y Ownership ' ' FIGURE. Outline of the 2-month periods defining the baseline and education years in the Minnesota Heart Health Program communities, E-3, E-2, E-, and E0 are the baseline years, and E-E6 are the education years. Hatched areas Indicate periods with data collection and event validation that was used for definition of first events but not for the final analyses. standard approach to data on enzyme patterns and electrocardiographic recordings obtained from the medical records. The records were abstracted by trained nurse abstractors under the supervision of a physician. A prerequisite for validation as definite myocardial infarction was the availability of data on the enzymes creatinine phosphokinase or creatinine phosphokinase-myocardial band. In the absence of enzymes or the presence of a normal enzyme pattern, the case could not be classified as definite. Table 2 shows the algorithm for classification of an enzyme pattern as abnormal or equivocal for the two enzyme measures. All events with abnormal enzyme patterns were classified as definite. With an equivocal enzyme pattern, the case was classified as definite when electrocardiograms showed "evolving evidence" of myocardial infarction: a minimum of two recorded electrocardiograms with an evolving Q-wave pattern, or ST-segment depression or elevation or T-wave inversion, in the setting of equivocal Q waves. This method, which uses a special Minnesota electrocardiographic code (36), is described in detail elsewhere (3). Out-of-hospital myocardial infarction. The second TABLE 2. Algorithm used for classification of enzyme patterns in coronary heart disease cases for which data were abstracted from medical records for validation, Minnesota Heart Health Survey, CPK-MB* data missing CPK-MB <00%f or negative CPK-MB 00-99% or positive CPK-MB 0% CPK'data missing CPK <0O%t CPK 00-99% CPK io% Normal Equivocal Normal Normal Equivocal Equivocal Equivocal Equivocal * CPK, creatinine phosphokinase; CPK-MB, creatinine phosphokinase-myocardial band. t Percentage of the reference value at each hospital. Negative/positive refers to cases in which the actual CPK-MB value was not provided. Am J Epidemiol Vol. 44, No. 4, 996

4 354 Luepker et al. category comprised only fatal cases and was based on computerized information from the mortality registers of the three state health departments. Cases were abstracted for residents in the MHHP communities aged 30-4 years with ICD-9-code(s) 40-44, 42.5, 428, or given as the underlying cause of death on the death certificate. The diagnosis was regarded as definite either when myocardial infarction was verified by autopsy records or when informant interviews, performed 2-4 years after the death, gave evidence of hospitalization due to acute myocardial infarction during the 4 weeks before death. These interviews were performed via telephone by trained interviewers according to a strict protocol. Sudden cardiac death. The third category was also based on computerized information from the death registers. All records on age-eligible MHHP resident cases with ICD-9-code(s) 40-44, 42.5, 428, or given as the underlying cause of death were abstracted. The diagnosis was regarded as valid when the informant interview indicated that death had occurred within hour of acute cardiac symptoms or within hour of the last observation with no symptoms. Definite fatal out-of-hospital coronary heart disease. The fourth category included age-eligible MHHP resident fatal cases occurring out-of-hospital, with ICD-9 code(s) given as the underlying cause of death and an informant interview or autopsy indicating a history of myocardial infarction or severe coronary artery disease or death within - hours after the onset of symptoms. Validation of definite acute stroke For stroke, patients residing in one of the MHHP communities who were discharged from any of the participating hospitals (alive or dead) with any of the ICD-9 codes 40, 4, 430-4, 4, 436, or 43 were selected, and data were validated using information abstracted from the medical records. A case was excluded when physician findings, computerized tomography, or autopsy gave evidence of brain tumor or metastasis, epidural or subdural hematoma, subarachnoid hemorrhage, systemic embolism, or a comatose state of any other origin (e.g., hepatic, diabetic, hypoglycemic, uremic, or epileptic). Following these exclusions, a case was labeled "definite" if an autopsy demonstrated evidence of cerebral infarction or cerebral hemorrhage. When an autopsy was not performed, all three of the following criteria were required: ) a localizing neurologic deficit and/or a change in the patient's state of consciousness, with a history of rapid onset (less than 48 hours from onset to time of admission or to maximum acute neurologic deficit or death); 2) documentation of the localizing neurologic deficit by unequivocal physical or laboratory findings (computerized tomography showing evidence of either cerebral hemorrhage or cerebral infarction) within 6 weeks of the onset of symptoms; and 3) more than hours' duration of unequivocal physical findings, or findings leading to death, or death within hours after onset of symptoms. Definition of fatality Irrespective of whether a hospitalized patient was discharged ah've or dead, an event was defined as fatal if death occurred within 28 days of admission to hospital. This classification was obtained by record linkage between the MHHP case register and the state health department mortality registers. Elimination of repeat events The present study included the first event in the study period for each subject. In the case of multiple events, definite in-hospital myocardial infarction took priority over definite out-of-hospital coronary heart disease or sudden cardiac death. If, in one subject, there remained more than one in-hospital myocardial infarction, the first of those events was selected. However, one subject could contribute to both the register of definite coronary heart disease and the register of definite stroke on separate occasions for example, by having a definite stroke followed by a fatal definite coronary heart disease event. Assignment of events to baseline and education years Each validated event was assigned to a specific 2-month period based on the date of hospital admission for hospitalized cases and the date of death for nonhospitalized cases. For each pair of communities, the annual start of a new year was defined as the month in which the intervention program began in the intervention community of the pair (figure ). This gave one complete baseline year (E0) and one incomplete baseline year (0 months during E-l) in and. In Fargo-Moorhead and Sioux Falls, there were three complete baseline years (E-2, E-l, and E0) and one incomplete baseline year (8 months during E-3). Events that occurred during all of these months were used in the analyses, together with those of the four complete baseline years in and. However, the first 2 months of 980 in and were not included in the analysis.

5 Community Education for Cardiovascular Disease Prevention 355 For education years, only those years having complete data from all six communities were used. Therefore, events that occurred after November, 98, in and ; after September, 989, in Fargo-Moorhead and ; and after March, 990, in and were not used. This left six complete education years for each community pair (E-E6). Thus, E-3, E-2, E-l, and E0 were the consecutive 2-month periods before intervention began, and E-E6 were the 2-month periods of intervention. Statistical methods Rates specific to sex, community intervention, year, and 5-year age stratum were calculated as events per person-year of exposure. Population sizes in each community were taken from the US Censuses for 980 and 990, by sex and 5-year age group. Person-years of exposure by sex, age group, and community were estimated by linear interpolation of the census figures, allowing for the time offsets between baseline/education year and calendar year. Rates were standardized to the 985 age structure of all MHHP communities. Weights were assigned to each rate, reflecting the number of person-years involved. The analysis method was the same as that used with MHHP cross-sectional risk factors, and it is described in detail elsewhere (38). The mixed-model regression analysis was carried out using the MIXED procedure of the Statistical Analysis System (SAS Institute, Inc., Cary, North Carolina; version 6.09). The unit of analysis was the city-year mean, each weighted by personyears of exposure. Year and the MHHP intervention were treated as fixed effects, and community was treated as a nested random effect. A common linear secular trend was estimated from all years (including E-3 and E-2) in comparison communities and from years prior to E3 in the education communities. The MHHP intervention was represented by a series of year-specific departures from that secular trend, beginning in E3, to allow for an a priori 2-year lag postulated between any risk factor effect and an impact on morbidity and mortality. Men and women were analyzed separately. and had no data for the years E-3 and E-2. This was not a problem in the mixed-model regression analysis, but it prevented calculation of pooled education and comparison mean rates for those years without assumptions about the missing rates. For presentation of those pooled rates, shown in the lefthand panels of figures 2 and 3, we avoided assumptions and calculated weighted mean rates for only the years E-l through E6; however, to aid interpretation, we shifted the rate in each community in each year by a constant community-specific amount to equalize the weighted mean rates in the education and comparison conditions in years E-l through E2. RESULTS Coronary heart disease A total of 4,9 cases of definite coronary heart disease occurred during follow-up, 3,66 (4.4 percent) in men and,9 (.6 percent) in women. As table 3 shows, the proportion of fatal cases did not differ between men (3.9 percent) and women (36.9 percent) (p = 0.6). Among fatal events, the most striking sex difference was a higher proportion of sudden cardiac death in men (3. percent; 54/,386) than in women (.4 percent; 09/465) (p < 0.000). Of the total number of cases, 2,394 (48. percent) occurred in the education communities and 2,526 (5.3 percent) in the comparison communities. Within each community, there was large year-to-year variation in the number of events (Appendix table ). This variability is reflected in the community-, year-, and sex-specific age-adjusted yearly event rates presented in table 4. For the years when data from all communities were available, adjusted event rates for the pooled education and comparison communities are presented in the left-hand panel of figure 2. In these aggregated data, there was also large variation, but striking symmetry was seen between the two sets of communities, especially for men. Application of the mixed-model regression analysis confirmed a downward linear trend in the event rate for both men and women. The event rate for coronary heart disease decreased by.8 percent per year for men (p for slope = 0.03) and 3.6 percent per year for women {p for slope = 0.00); these secular trends are TABLE 3. Distribution of the subclasses of definite coronary heart disease and stroke among men and women, Minnesota Heart Health Survey, No. Men No. Women Nonfatal acute myocardia) infarction 2, Fatal acute myocarcfial infarction, In-hospital fatal acute myocardal infarction Out-of-hospital acute myocardal infarction Sudden candfiac death Definite fatal coronary heart disease All definite coronary heart dsease 3, , All definite stroke (in-hospital only)

6 356 Luepker et al. TABLE 4. Age-standardized rates (per 00,000 person-years]) of definite coronary heart disease (fatal and nonfatal combined) in men and women aged 30-4 years when the event occurred, Mnnesota Heart Health Program, * Education year Community E-3 E-2 E- EO E E2 E3 E4 E5 E6 Men Fargo-Moo rhead Woman Fargo-Moo rhead * The standard population was the total population aged 30-4 years in the six study communities plotted in the right-hand panel of figure 2. Also shown in figure 2 are the annual deviations from the trend observed in the three education communities, along with 95 percent confidence intervals; all of these confidence intervals overlapped the fitted secular trend, and none of the annual deviations were statistically significant. Fitted linear trends for the education communities during years E3-E6, forced through the origin at E2 (the latest point prior to the hypothesized intervention effect), had slopes that were not different from those of the unconstrained secular trends among men and women. An age-stratified analysis showed similar results, with no significant MHHP effects for ages above and below 65 years. The same was true for a subgroup analysis restricted to fatal cases. Stroke A total of,55 patients had a definite stroke; 90 strokes (58.3 percent) occurred in men and 650 (4. percent) in women (table 3). Of the total number, 8 (52.5 percent) strokes occurred in the education communities and 39 (4.5 percent) in the comparison communities. Just as for coronary heart disease, there was considerable variation between the annual numbers of events (Appendix table 2). This variability was again reflected in the community-, year-, and sex-specific age-adjusted yearly event rates presented in table 5. For the years when data from all cities were available, adjusted event rates for the intervention and comparison areas are presented in the left-hand panel of figure 3. The mixed-model regression analysis revealed no significant linear secular trends for stroke. In men, the mean annual change was a decline of 0.5 percent per year relative to the level at El (p for slope = 0.8), and in women there was an increase of 2.3 percent per year (p for slope = 0.36). Also shown in figure 3 are the annual deviations from the trend for the intervention communities, with 95 percent confidence intervals. As for coronary heart disease, all confidence intervals for stroke overlapped the fitted trend, and none of the annual deviations were statistically significant. The fitted linear trend for stroke in years E3-E6, forced through the origin at E2, did not deviate significantly from the secular trend. None of the above results changed with stratification by age. DISCUSSION This paper reports the final results of one of the most complex community trials yet conducted in cardiovascular disease prevention. To our knowledge, it is the first to provide controlled data on the possible impact of a community-wide intervention on fatal and nonfatal cardiovascular disease rates. The results are clear: There was no evidence of a significant intervention effect on morbidity or mortality, either for coronary heart disease or for stroke. This is not surprising, given the recently published risk factor findings from the MHHP () and given the strong and favorable secular trends in coronary heart disease risk with which the intervention program had to compete. We recently reported that the MHHP had only modest effects on population risk factor levels (). That report also documented the strong, 2-3 percent annual decline in a coronary heart disease risk

7 Community Education for Cardiovascular Disease Prevention 35 POOLED AND AGE-STANDARDIZED EVENT RATES FITTED SECULAR TREND AND MHHP EFFECT ESTIMATES 500" Male* " c^- 400" T ~~~ - =LJ EDUCATION YEAR o- i r EDUCATION YEAR EDUCATION COMMUNTTES COMPARISON COMMUNmES - EDUCATION EFFECT, I 95% CONFIDENCE BOUNDS SECULAR TREND FIGURE 2. Effect of a community education program on definite coronary heart disease rates among 30- to 4-year-old men and women in the Minnesota Heart Health Program (MHHP), All results are standardized to the mean population of subjects aged 30-4 years in the study communities. Left panel: Age-standardized event rates, pooled between communities using numbers of personyears In each community as weights. The rates were adjusted to provide a common mean level between educated and comparison communities during baseline and lag periods (E- through E2). Right panel: Fitted secular trend and annual MHHP effect estimates; bars, 95% confidence intervals. score for comparison communities (39, 40) during the MHHP intervention period. In the MHHP, the annual decline in coronary heart disease event rates in comparison communities was.8 percent in men and 3.6 percent in women. Both slopes were statistically significant. This corresponds to an accumulated decrease during the 4 years of observation (E2-E6) of.2 percent in men and 4.4 percent in women. It now seems unlikely that a project using local methods of public education would be able to augment this significant background trend over such a short period. Such trends were not anticipated when the MHHP was designed in the late 90s. In contrast, secular trends in stroke were less striking. While stroke mortality continued to decline nationally during the 980s, it plateaued in the Minnesota Heart Survey communities (Minneapolis-St. Paul) from 980 to 990 (). National data on stroke morbidity during the same interval are lacking, but the Minneapolis-St. Paul age-adjusted in-hospital event rate for stroke declined from 980 to 985, from,03 to 988 per 00,000 male inhabitants and from 926 to 804 in women (). Simultaneously, the proportion of in-hospital definite stroke (validated as in the MHHP) increased from 43 percent to 50 percent in men and from 4 percent to 5 percent in women (). Together, the Minnesota Heart Survey data indicate no trend in the definite stroke rate in men and an increase of about 2.5 percent per year in women. The pattern corresponds well with the observations of the MHHP. One possible reason for this break in the continuous decline in stroke incidence is ascertainment bias due to increasing use of computerized tomography (). Therefore, it is possible that the MHHP intervention was competing with downward population trends in stroke incidence as well. The fact that the MHHP was unable to demonstrate improved prevention of first stroke was also expected in view of the intervention's limited impact on average blood pressure levels in the education communities relative to the reference communities notably on the

8 358 Luepker et al. TABLE 5. Age-standardized rates (per 00,000 person-years) of definite in-hospital stroke (fatal and nonfatal combined) In men and women aged 30-4 years when the event occurred, Minnesota Heart Health Program, * Education year Community E-3 E-2 E- E0 E E2 E3 E4 E5 E6 Men Fargo-Moorhead Women Fargo-Moorhead * The standard population was the total population aged 30-4 years in the six study communities prevalence of treatment for hypertension and on blood pressure levels in treated patients (, 4). The North Karelia Project published morbidity data for the first 5 years of intervention (), but the design was not controlled, and in view of the strong secular trends in Finland, the findings are not conclusive of an intervention effect. The Finnish investigators have continued to compare coronary heart disease mortality rates in North Karelia with those in the reference community and in all of Finland. They demonstrated more rapidly declining rates during the first years in the intervention community than in these reference populations (). The North Karelia Project may have achieved some acceleration of a strong secular trend, but whether this should be attributed to the intervention program has been questioned (42). There were also fundamental differences in the circumstances in which the North Karelia Project and the MHHP were conducted. The Finnish project was instituted in 92 in a part of Europe that had some of the highest coronary heart disease rates in the world, with the levels of related risk factors being extremely high. The MHHP, on the other hand, involved populations at or below the average risk of populations in other industrialized countries. Thus, while there were downward secular trends in both areas, the rates moved from extremely high to high in North Karelia while staying within the medium range in Minnesota. The MHHP was started 0-2 years later than the Finnish study, when interest in coronary heart disease prevention in clinical medicine and the mass media was already high. In the United States, the National High Blood Pressure Education Program (43) was well along, and the National Cholesterol Education Campaign (44) had begun. For many years, Minnesota also had an integrated program of legislation regarding the control of smoking in public areas. Thus, Minnesota was already in an accelerated phase of risk reduction when the MHHP began. These differences may well be the most important reasons for the difference in outcome from the Finnish project. Neither the North Karelia Project nor the MHHP appeared to have any impact on stroke rates. This may be a consequence of the relatively lesser emphasis placed on a high-risk approach. An aggressive program for identification and treatment of hypertension can influence the incidence of stroke in the population, as was recently demonstrated in a Swedish trial (45). Other community trials have reported effects on risk factor levels. Favorable results were described by the Stanford Five-City Project (8) and the German Cardiovascular Prevention Study (4), while the Pawtucket Heart Health Program (2) and the Heartbeat Wales Programme (C. Smith, Health Promotion Wales, personal communication, 994) had ambiguous results similar to those of the MHHP. The cardiovascular event rates of these studies have not yet been reported at diis writing. Methodological considerations Several methodological issues warrant further consideration. First, hospital morbidity data and death certificate data became available annually, and this created a mismatch between those data and the MHHP education schedule, leaving incomplete years at the end of the MHHP (figure ). We considered using the rates from all partial years, weighting by person-years of exposure. However, in the presence of a measurable trend, this procedure would lead to bias in the full-year

9 Community Education for Cardiovascular Disease Prevention 359 POOLED AND AGE-STANDARDIZED EVENT RATES FITTED SECULAR TREND AND MHHP EFFECT ESTIMATES y - / 00- Mate 80-60" 40- Females T~ < -^ " EDUCATION YEAR o- I EDUCATION YEAR EDUCATION COUHUNTTES COMPARISON COMMUNITIES I EDUCATION EFFECT, 95% CONFIDENCE BOUNDS SECULAR TREND FIGURE 3. Effect of a community education program on definite in-hospital stroke rates among 30- to 4-year-old men and women in the Minnesota Heart Health Program (MHHP), All results are standardized to the mean population of subjects aged 30-4 years in the study communities. Left panel: Age-standardized event rates, pooled between communities using numbers of person-years in each community as weights. The rates were adjusted to provide a common mean level between educated and comparison communities during baseline and lag periods (E- through E2). Right panel: Fitted secular trend and annual MHHP effect estimates; bars, 95% confidence intervals. estimates, and further bias would arise from the shifting relative contribution of each pair in those partial years. We chose to use data weighted by person-years only if the partial year included at least 8 months of data for each of the two largest pairs. Second, only events validated as definite were used to calculate rates, although other events were recorded as possible events when they did not meet the full criteria for definite coronary heart disease or stroke. Because a combined analysis of definite plus possible events showed virtually the same results as those presented here, we limited this presentation to definite events. There are also two issues related to the regression analysis we used. We conducted analysis at the community level, fitting a regression model to the agestandardized annual rates from the six MHHP communities. Such an analysis is appropriate, given the allocation of intact communities to the intervention and comparison groups, and has been widely recommended (46-50). However, a common concern with such analyses is their low statistical power. In planning the study, we had projected 85 percent power to detect net differences in coronary heart disease mortality of 5- percent over 6 years, based on an analysis of men and women pooled, comparing the three intervention communities with the entire states of Minnesota, North Dakota, and South Dakota. The detectable difference for stroke mortality had been estimated to be about 35 percent over a 6-year period. As the analysis progressed, it became clear that the effects were different in men and women, such that pooling no longer made sense. In addition, as the modest differences emerged, it also became clear that there was little point in comparing the intervention communities with the three states, particularly when that analysis would be restricted to deaths based on unvalidated state death tapes. We knew that statistical power would be reduced for sex-specific analyses comparing the education and comparison communities alone. Now we believe that these analyses are more informative than those origi-

10 360 Luepker et al. nally envisioned. Given 80 percent statistical power and based on observed variations in the data, the detectable net differences over 5 years for coronary heart disease and stroke in the analyses reported here were 28.3 percent and 58.3 percent, respectively, for men and 49.6 percent and 62. percent, respectively, for women. While the power to detect 5- percent net differences was well below 85 percent, we do not attribute the results reported here to low power. Rather, they appear to be due to a lack of substantial, lasting differences between the intervention and comparison communities in levels of coronary heart disease risk factors and subsequent morbidity and mortality. In addition, the regression analysis assumed a common linear secular trend. This is important, because the imposition of a linear trend influenced the MHHP intervention effect estimates computed as yearspecific departures from that trend. A comparison of the left- and right-hand panels in figures 2 and 3 confirms that the model fitted the data reasonably well for stroke but less well for coronary heart disease. A paired-difference model would have avoided this problem, but it would have provided considerably less power (only df), would not have estimated the secular trend, and would have substituted one set of assumptions for another. Because any model is an imperfect simplification of the underlying data, we have shown both the left- and right-hand panels in figures 2 and 3, as well as the age-standardized rates presented in tables 4 and 5, to assist the reader in interpreting these results. Finally, we acknowledge that randomization was not employed in the MHHP design. Given the few communities in the study, simple randomization had little likelihood of achieving comparability between the intervention and comparison areas. More recent trials have used a greater number of units (5); under these conditions, randomization has a greater Likelihood of achieving comparability between intervention and comparison areas. In the MHHP, adjustment was possible for some baseline characteristics that should have been balanced by randomization (sex and age distributions and disease incidence rates). Other characteristics of the communities that were potentially important to the outcome (e.g., educational level) could not be considered. Conclusions The Minnesota Heart Health Program was launched during a decade of strongly declining secular trends in cardiovascular disease risk in Minnesota and nationally. Although individual elements of the intervention programs had the effects intended (30-33), the program as a whole did not accelerate risk reduction beyond those trends. However, the MHHP, along with related programs in California () and Rhode Island (3), has influenced national programs and policies. That may, in turn, have influenced the comparison communities in these studies as well as the national trends. Many reports have appeared on the success of individual intervention efforts within the framework of the community projects, and those publications have probably served as a stimulus for other investigators and policy-makers. The problems involved in conducting large-scale community trials are widely acknowledged today (52, 53). Investigators should benefit from this experience in planning future study designs and interventions. ACKNOWLEDGMENTS This research was supported by a grant from the National Heart, Lung, and Blood Institute (RO HL 5). Dr. Rastam was supported by grants from the Swedish Medical Research Council, the Swedish Society of Medicine, and the Johan and Henning Throne Hoist Foundation. The authors acknowledge the many staff who worked in the MHHP and the cooperation of the citizens of the six study communities. REFERENCES. Keys A, ed. Coronary heart disease in seven countries. Dallas, TX: American Heart Association, 90. (American Heart Association monograph no. ). 2. World Health Organization. World health statistics annual. Geneva, Switzerland: World Health Organization, Stamler J. The marked decline in coronary heart disease mortality rates in the United States, : summary of findings and possible explanations. Cardiology 985;2: Whisnant JP. The decline of stroke. Stroke 984;5: Burke GL, Sprafka JM, Folsom AR, et al. Trends in CHD mortality, morbidity and risk factor levels from 960 to 986: The Minnesota Heart Survey. Int J Epidemiol 989;(suppl ):S3-S8. 6. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 994;309:-.. McGovem PG, Burke GL, Sprafka M, et al. Trends in mortality, morbidity, and risk factor levels for stroke from 960 through 990: The Minnesota Heart Survey. JAMA 992;268: Farquhar JW, Maccoby N, Wood PD, et al. Community education for cardiovascular health. Lancet 9;: Puska P, Toumilehto J, Salonen J, et al. The North Karelia Project: community control of cardiovascular disease. Evaluation of a comprehensive community programme for control of cardiovascular diseases in 92-9 in North Karelia, Finland. Copenhagen, Denmark: World Health Organization, Gutzwiller F, Nater B, Martin J. Community-based primary prevention of cardiovascular disease in Switzerland: methods and results of the National Research Program (NRP A). Prev Med 985;4:482-9.

11 Community Education for Cardiovascular Disease Prevention 36. Farquhar JW, Fortmann SP, Maccoby N, et al. The Stanford Five-City Project: design and methods. Am J Epidemiol 985; : Mittelmark MB, Luepker RV, Jacobs DR, et al. Communitywide prevention of cardiovascular disease: education strategies of the Minnesota Heart Health Program. Prev Med 986; 5:-. 3. Elder JP, McGraw SA, Abrams DB, et al. Organizational and community approaches to community-wide prevention of heart disease: the first two years of the Pawtucket Heart Health Program. Prev Med 986;5: GCP Study Group. The German Cardiovascular Prevention Study (GCP): design and methods. Eur Heart J 988;9: Nutbeam D, Catford J. The Welsh Heart Health Programme evaluation strategy: progress, plans and possibilities. Health Promotion 98;2:5. 6. Salonen JT, Puska P, Kottke TE, et al. Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program: The North Karelia Project. Am J Epidemiol 98;4: Puska P, Salonen JT, Nissinen A, et al. Change in risk factors for coronary heart disease during 0 years of a community intervention programme (North Karelia Project). Br Med J 983;28: Puska P, Toumilehto J, Nissinen A, et al. The North Karelia Project: 5 years of community-based prevention of coronary heart disease. Ann Med 989;2: Farquhar JW, Fortmann SP, Flora JA, et al. Effects of communitywide education on cardiovascular disease risk factors: The Stanford Five-City Project JAMA 990;264: Luepker RV, Murray DM, Jacobs DR Jr, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health 994;84: Carleton R, Lasater TM, Assaf AR, et al. The Pawtucket Heart Health Program: cross-sectional results from a community intervention trial. (Abstract). Circulation 994;89:9.. Greiser E, Hoffmeister H, Hoeltz J, et al. Final risk factor changes after years of a multicenter community intervention program: The German Cardiovascular Prevention Study (GCP). (Abstract). Circulation 994;89:933.. Salonen JT, Puska P, Mustaniemi H. Changes in morbidity and mortality during comprehensive community programme to control cardiovascular diseases during 92- in North Karelia. Br Med J 99;2: Tuomilehto J, Geboers J, Salonen JT, et al. Decline in cardiovascular mortality in North Karelia and other parts of Finland. BrMedJ 986;3: Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice-Hall, Inc, Hovland CI, Janis IL, Kelley HH. Communication and persuasion: psychological studies of opinion change. New Haven, CT: Yale University Press, McGuire WJ. Persuasion, resistance and attitude change. In: DeSola I, Schramm W, eds. Handbook of communication. Chicago, IL: Rand-McNally and Company, 93: Rothman J. Three models of community organization practice. In: Cox FM, Erlich JL, Rothman J, et al, eds. Strategies of community organization: a book of readings. Itasca, IL: FE Peacock Publishers, 90:-36.. Viswanath K, Finnegan JR, Hannan P, et al. Health and knowledge gaps: some lessons from the Minnesota Heart Health Program. Am Behav Scientist 99;: Murray DM, Luepker RV, Pirie PL, et al. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Prev Med 986; 5: Glantz K, Mullis RM. Environmental interventions to promote healthy eating: a review of models, programs and evidence. Health Educ Q 988;5: Perry CL, Klepp KI, Sillers C. Community-wide strategies for cardiovascular health: the Minnesota Heart Health Program youth program. Health Educ Res 989;4: Mittelmark MB, Luepker RV, Grimm R Jr, et al. The role of physicians in a community-wide program for prevention of cardiovascular disease: The Minnesota Heart Health Program. Public Health Rep 988; 03: Jacobs DR Jr, Luepker RV, Mittelmark M, et al. Communitywide prevention strategies: evaluation design of the Minnesota Heart Health Program. J Chronic Dis 986;39: World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Vol. Geneva, Switzerland: World Health Organization, Rose GA, Blackburn H. Cardiovascular survey methods. Geneva, Switzerland: World Health Organization, 968. (WHO Monograph Series no. 56). 3. Mascioli SR, Jacobs DR Jr, Kottke TE. Diagnostic criteria for hospitalized acute myocardial infarction: the Minnesota experience. Int J Epidemiol 989;: Murray DM, Hannan PJ, Jacobs DR, et al. Assessing intervention effects in the Minnesota Heart Health Program. Am J Epidemiol 994;39: Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 96;: Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis 98;40: Rfistam L, Hannan PJ, Jacobs DR Jr, et al. Population and physician behavior and blood pressure trends: The Minnesota Heart Health Program (MHHP). (Abstract). Circulation 994; 89: Salonen JT. Did the North Karelia project reduce coronary mortality? (Letter). Lancet 98;2: US National Heart and Lung Institute. National Conference on High Blood Pressure Education. Bethesda, MD: National Heart and Lung Institute, 93. (DHEW publication no. (NIH) 3-486). 44. Lenfant C. A new challenge for America: The National Cholesterol Education Program. Circulation 986;3: Lindblad U, RAstam L, Ryd6n L, et al. Reduced stroke incidence with structured hypertension care: The Skaraborg Hypertension Project. J Hypertens 990;8: Zucker DM. An analysis of variance pitfall: the fixed effects analysis in a nested design. Educ Psychol Meas 990;50: Koepsell TD, Martin DC, Diehr PH, et al. Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs: a mixed-model analysis of variance approach. J Clin Epidemiol 99 ;44: Murray DM, McKinlay SM, Martin D, et al. Design and analysis issues in community trials. Eval Rev 994; : Donner A, Klar N. Cluster randomization trials in epidemiology: theory and application. J Stat Plann Inference (in press). 50. Murray DM. Design and analysis of community trials: lessons from the Minnesota Heart Health Program. Am J Epidemiol 995;42: Gail MH, Byar DP, Pechacek TF, et al. Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Controlled Clin Trials 992;3: Blackburn H. Community programs in coronary heart disease prevention and health promotion: changing community behavior. In: Marmot MG, Elliott P, eds. Coronary heart disease epidemiology: from aetiology to public health. New York, NY: Oxford University Press, 992: Winkleby MA. The future of community-based cardiovascular disease intervention studies. (Editorial). Am J Public Health 994;84:369-2.

12 362 Luepker et al. APPENDIX TABLE. Numbers of definite coronary heart disease event* (fatal and nonfatal combined) in men and women aged 30-4 years when the event occurred, Minnesota Heart Health Program, Education year Community E-3 E-2 E- EO E E2 E3 E4 E5 E6 Men Fargo-Moorhead 4f 3f * 9* Woman Fargo-Moorhead lit 2f * 2* * During a 0-month period, t During an 8-month period. APPENDIX TABLE 2. Numbers of definite stroke events (fatal and nonfatal combined) in men and women aged 30-4 years when the event occurred, Minnesota Heart Hearth Program, Education year Community E-3 E-2 E- EO E E2 E3 E4 E5 E6 Man Fargo-Moorhead 2f t 2 5* 9* Women Fargo-Moorhead * During a 0-month period, t During an 8-month period. lit 2f * 5*

The Long-Term Effects of a Cardiovascular Disease Prevention Trial: The Stanford Five-City Project

The Long-Term Effects of a Cardiovascular Disease Prevention Trial: The Stanford Five-City Project The Long-Term Effects of a Cardiovascular Disease Prevention Trial: The Stanford Five-City Project MarilynA. Winkleby, PhD, C. Barr Taylor, MD, Darius Jatulis, MS, and Stephen P. Fortmann, MD Introduction

More information

Managing the global burden of cardiovascular disease

Managing the global burden of cardiovascular disease European Heart Journal Supplements (2002) 4 (Supplement F), F2 F6 Managing the global burden of cardiovascular disease B. Neal, N. Chapman and A. Patel Institute for International Health, Sydney, New South

More information

National public health campaigns have attempted

National public health campaigns have attempted WINTER 2005 PREVENTIVE CARDIOLOGY 11 CLINICAL STUDY Knowledge of Cholesterol Levels and Targets in Patients With Coronary Artery Disease Susan Cheng, MD; 1,2 Judith H. Lichtman, MPH, PhD; 3 Joan M. Amatruda,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular

More information

Risks of mild hypertension: a ten-year report

Risks of mild hypertension: a ten-year report British HeartJournal, I971 33, Supplement, II6-I2I. Risks of mild hypertension: a ten-year report Oglesby Paul' From the Participating Centers in the Pooling Project of the Council on Epidemiology of the

More information

Comparison of trends in ischaemic heart disease between North Karelia, Finland, and Kaunas,

Comparison of trends in ischaemic heart disease between North Karelia, Finland, and Kaunas, 516 Br Heart J 1992;68:516-23 EPIDEMIOLOGY Institute of Cardiology, Kaunas, Lithuania D Rastenyte D Rasteniene R Grazuleviciene Z Cepaitis J Bluzhas Department of Epidemiology, National Public Health Institute,

More information

Stroke patients constitute an increasing challenge

Stroke patients constitute an increasing challenge 236 Outcome After Stroke in Patients Discharged to Independent Living Margareta Thorngren, MD, Britt Westling, MD, and Bo Norrving, MD In a prospective, population-based study, we evaluated rehabilitation

More information

in Two South Carolina Communities

in Two South Carolina Communities Self-Reported Frequency of Serum Cholesterol Testing, Awareness of Test Results, and Laboratory Cholesterol Values in Two South Carolina Communities GREGORY W. HEATH, DHSc, MPH ERKKI VARTIAINEN, MD,.PhD

More information

Community intervention programs to prevent cardiovascular disease

Community intervention programs to prevent cardiovascular disease 1 (7) Community intervention programs to prevent cardiovascular disease SBU Summary and Conclusions Introduction The prevention of disease is a mission of major importance to society and the individual.

More information

Age-adjusted mortality from coronary heart disease (CHD)

Age-adjusted mortality from coronary heart disease (CHD) Clinical Investigation and Reports Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997 The Minnesota Heart Survey Paul G. McGovern, PhD; David R. Jacobs,

More information

Diabetes and Decline in Heart Disease Mortality in US Adults JAMA. 1999;281:

Diabetes and Decline in Heart Disease Mortality in US Adults JAMA. 1999;281: ORIGINAL CONTRIBUTION and Decline in Mortality in US Adults Ken Gu, PhD Catherine C. Cowie, PhD, MPH Maureen I. Harris, PhD, MPH MORTALITY FROM HEART disease has declined substantially in the United States

More information

Relative Impact of Targeted Versus Populationwide Cholesterol Interventions

Relative Impact of Targeted Versus Populationwide Cholesterol Interventions 254 Relative Impact of Targeted Versus Populationwide Cholesterol Interventions on the Incidence of Coronary Heart Disease Projections of the Coronary Heart Disease Policy Model Lee Goldman, MD, MPH, Milton

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 339 S EPTEMBER 24, 1998 NUMBER 13 TRENDS IN THE INCIDENCE OF MYOCARDIAL INFARCTION AND IN MORTALITY DUE

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant

More information

Page down (pdf converstion error)

Page down (pdf converstion error) 1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999

More information

Determinants of the decline in mortality attributable

Determinants of the decline in mortality attributable Temporal Trends in the Incidence of Coronary Disease Theresa J. Arciero, Steven J. Jacobsen, MD, PhD, Guy S. Reeder, MD, Robert L. Frye, MD, Susan A. Weston, MS, Jill M. Killian, BS, Véronique L. Roger,

More information

RATES of mortality from coronary heart disease

RATES of mortality from coronary heart disease 884 THE NEW ENGLAND JOURNAL OF MEDICINE April 4, 1996 RECENT TRENDS IN ACUTE CORONARY HEART DISEASE Mortality, Morbidity, Medical Care, and Risk Factors PAUL G. MCGOVERN, PH.D., JAMES S. PANKOW, M.P.H.,

More information

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,

More information

Predicting cardiovascular risk in the elderly in different European countries

Predicting cardiovascular risk in the elderly in different European countries European Heart Journal (2002) 23, 294 300 doi:10.1053/euhj.2001.2898, available online at http://www.idealibrary.com on Predicting cardiovascular risk in the elderly in different European countries S.

More information

Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study

Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study 80 Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study Thomas Truelsen, MB; Ewa Lindenstrtfm, MD; Gudrun Boysen, DMSc Background and Purpose We wished to

More information

Patterns of adolescent smoking initiation rates by ethnicity and sex

Patterns of adolescent smoking initiation rates by ethnicity and sex ii Tobacco Control Policies Project, UCSD School of Medicine, San Diego, California, USA C Anderson D M Burns Correspondence to: Dr DM Burns, Tobacco Control Policies Project, UCSD School of Medicine,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

Chest pain and subsequent consultation for coronary heart disease:

Chest pain and subsequent consultation for coronary heart disease: Chest pain and subsequent consultation for coronary heart disease: a prospective cohort study Peter R Croft and Elaine Thomas ABSTRACT Background Chest pain may not be reported to general practice but

More information

D espite a distinct decline in ischaemic heart disease

D espite a distinct decline in ischaemic heart disease RESEARCH REPORT Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50 000 Norwegian

More information

Risk Associated with Various Definitions of Family History of Coronary Heart Disease

Risk Associated with Various Definitions of Family History of Coronary Heart Disease American Journal of Epidemiology Copyright 998 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 47, No. 2 Printed in U.S.A. Risk Associated with Various Definitions

More information

Natural History of Stroke in Rochester, Minnesota, 1955 Through 1969: An Extension of a Previous Study, 1945 Through 1954

Natural History of Stroke in Rochester, Minnesota, 1955 Through 1969: An Extension of a Previous Study, 1945 Through 1954 Natural History of Stroke in Rochester, Minnesota, Through : An Extension of a Previous Study, Through BY NOBUTERU MATSUMOTO, M.D./ JACK P. WHISNANT, M.D., LEONARD T. KURLAND, M.D., AND HARUO OKAZAKI,

More information

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.

More information

Q. Qiao 1, M. Tervahauta 2, A. Nissinen 2 and J. Tuomilehto 1. Introduction

Q. Qiao 1, M. Tervahauta 2, A. Nissinen 2 and J. Tuomilehto 1. Introduction European Heart Journal (2000) 21, 1621 1626 doi:10.1053/euhj.2000.2151, available online at http://www.idealibrary.com on Mortality from all causes and from coronary heart disease related to smoking and

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

I n a previous article dealing with the Italian rural cohorts of

I n a previous article dealing with the Italian rural cohorts of 19 CARDIOVASCULAR MEDICINE Coronary risk factors predicting early and late coronary deaths A Menotti, M Lanti... See end of article for authors affiliations... Correspondence to: Dr M Lanti, Associazione

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Moran A, Zhao D, Gu D, et al. The Future Impact of Population

More information

YOUNG ADULT MEN AND MIDDLEaged

YOUNG ADULT MEN AND MIDDLEaged BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,

More information

Trends in Blood Pressure, Hypertension Control, and Stroke Mortality: The Minnesota Heart Survey

Trends in Blood Pressure, Hypertension Control, and Stroke Mortality: The Minnesota Heart Survey The American Journal of Medicine (2006) 119, 42-49 CLINICAL RESEARCH STUDY Trends in Blood Pressure, Hypertension Control, and Stroke Mortality: The Minnesota Heart Survey Russell V. Luepker, MD, a Donna

More information

TEN-YEAR ABSOLUTE RISK ESTImates

TEN-YEAR ABSOLUTE RISK ESTImates ORIGINAL CONTRIBUTION CLINICIAN S CORNER Lifetime Risk and Years Lived Free of Total Cardiovascular Disease Scan for Author Video Interview John T. Wilkins, MD, MS Hongyan Ning, MD, MS Jarett Berry, MD,

More information

<INSERT COUNTRY/SITE NAME> All Stroke Events

<INSERT COUNTRY/SITE NAME> All Stroke Events WHO STEPS STROKE INSTRUMENT For further guidance on All Stroke Events, see Section 5, page 5-15 All Stroke Events Patient Identification and Patient Characteristics (I 1) Stroke

More information

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort

More information

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart

More information

Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor

Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor Policy #: 239 Latest Review Date: July 2010 Category: Laboratory Policy Grade: Active

More information

The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D.

The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D. The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease William E. Feeman, Jr., M.D. 640 South Wintergarden Road Bowling Green, Ohio 43402 Phone 419-352-4665 Fax

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia (2004) 18, 545 551 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh REVIEW ARTICLE Prevalence, awareness, treatment and control of hypertension in North America,

More information

indicators: the Oslo study

indicators: the Oslo study Journal of Epidemiology and Community Health, 198, 34, 48-52 Four-year mortality by some socioeconomic indicators: the Oslo study I. HOLME, A. HELGELAND, I. HJERMANN, P. LEREN, AND P. G. LND-LARSEN From

More information

Cardiovascular risk factor changes in Finland,

Cardiovascular risk factor changes in Finland, International Epidemiological Association 2000 Printed in Great Britain International Journal of Epidemiology 2000;29:49 56 Cardiovascular risk factor changes in Finland, 1972 1997 Erkki Vartiainen, Pekka

More information

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY. OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY THE OREGON DEPARTMENT OF HUMAN SERVICES HEALTH SERVICES HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM www.healthoregon.org/hpcdp Contents

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

More information

Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey

Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey 1-28 Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey Richard J. Havlik, Andrea Z. LaCroix, Joel C. Kleinman, Deborah D. Ingram, Tamara Harris, and Joan Cornoni-Huntley

More information

Mortality following acute myocardial infarction (AMI) in

Mortality following acute myocardial infarction (AMI) in In-Hospital Mortality Among Patients With Type 2 Diabetes Mellitus and Acute Myocardial Infarction: Results From the National Inpatient Sample, 2000 2010 Bina Ahmed, MD; Herbert T. Davis, PhD; Warren K.

More information

Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 500 screen detected cases

Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 500 screen detected cases 5 J Med Screen 1999;6:5 54 Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 5 screen detected cases K A Vardulaki, T C Prevost, N M Walker, N E Day, A B M Wilmink, C R G Quick,

More information

Diagnostic Criteria for Hospitalized Acute Myocardial Infarction: The Minnesota Experience

Diagnostic Criteria for Hospitalized Acute Myocardial Infarction: The Minnesota Experience International Journal of Epidemiology International Epidemiological Association 989 Vol. 8, o. rinted in Great Britain iagnostic Criteria for Hospitalized Acute Myocardial Infarction: The Minnesota Experience

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

DIAGNOSTIC CRITERIA OF AMI/ACS

DIAGNOSTIC CRITERIA OF AMI/ACS DIAGNOSTIC CRITERIA OF AMI/ACS Diagnostic criteria are used to validate clinical diagnoses. Those used in epidemiological studies are here below reported. 1. MONICA - Monitoring trends and determinants

More information

Population-based stroke registries are the most important

Population-based stroke registries are the most important The Third Stroke Registry in Tartu, Estonia Decline of Stroke Incidence and 28-Day Case-Fatality Rate Since 1991 Riina Vibo, MD; Janika Kõrv, MD, PhD; Mai Roose, MD, PhD Background and Purpose The purpose

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

O besity is associated with increased risk of coronary

O besity is associated with increased risk of coronary 134 RESEARCH REPORT Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes S Goya Wannamethee, A Gerald Shaper, Mary Walker... See end of article for

More information

The effect of cholesterol-related knowledge on patients' ability to reach target cholesterol levels

The effect of cholesterol-related knowledge on patients' ability to reach target cholesterol levels Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 2003 The effect of cholesterol-related knowledge on patients' ability

More information

epidemiological studies: an alternative based on the Caerphilly and Speedwell surveys

epidemiological studies: an alternative based on the Caerphilly and Speedwell surveys Journal of Epidemiology and Community Health, 1988, 42, 116-120 Diagnosis of past history of myocardial infarction in epidemiological studies: an alternative based on the and surveys A BAKER,2 AND D BAINTON2.*

More information

Supplementary webappendix

Supplementary webappendix Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ray K K, Seshasai S R K, Wijesuriya S,

More information

C. Packham 1, D. Gray 2, P. Silcocks 3 and J. Hampton 2. Introduction

C. Packham 1, D. Gray 2, P. Silcocks 3 and J. Hampton 2. Introduction European Heart Journal (2000) 21, 213 219 Article No. euhj.1999.1758, available online at http://www.idealibrary.com on Identifying the risk of death following hospital discharge in patients admitted with

More information

ORIGINAL INVESTIGATION. Effects of Prehypertension on Admissions and Deaths

ORIGINAL INVESTIGATION. Effects of Prehypertension on Admissions and Deaths ORIGINAL INVESTIGATION Effects of Prehypertension on Admissions and Deaths A Simulation Louise B. Russell, PhD; Elmira Valiyeva, PhD; Jeffrey L. Carson, MD Background: The Joint National Committee on Prevention,

More information

A study of adverse reaction algorithms in a drug surveillance program

A study of adverse reaction algorithms in a drug surveillance program A study of adverse reaction algorithms in a drug surveillance program To improve agreement among observers, several investigators have recently proposed methods (algorithms) to standardize assessments

More information

Sodium and potassium excretion in a sample of

Sodium and potassium excretion in a sample of Journal of Epidemiology and Community Health, 1980, 34, 174-178 Sodium and potassium excretion in a sample of normotensive and hypertensive persons in eastern Finland JAAKKO TUOMILEHTO From the North Karelia

More information

Country report Serbia April 2017

Country report Serbia April 2017 Country report Serbia April 2017 Report by Vojislav Giga, MD, PhD, Cardiologist et al. National CVD Prevention Coordinator for Serbia Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia Prepared

More information

The Prevalence of Gout in Three English Towns

The Prevalence of Gout in Three English Towns International Journal of Epidemiology Oxford University Press 82 Vol. 11, No. 1 Printed in Great Britain The Prevalence of Gout in Three English Towns M J GARDNER*. C POWER". D J P BARKER* and R PADDAY*

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative

More information

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study 22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if

More information

Temporal Trends in Prevalence of Diabetes Mellitus in a Population-Based Cohort of Incident Myocardial Infarction and Impact of Diabetes on Survival

Temporal Trends in Prevalence of Diabetes Mellitus in a Population-Based Cohort of Incident Myocardial Infarction and Impact of Diabetes on Survival ORIGINAL TEMPORAL TRENDS ARTICLE IN PREVALENCE OF DM IN COHORT OF INCIDENT MI Temporal Trends in Prevalence of Diabetes Mellitus in a Population-Based Cohort of Incident Myocardial Infarction and Impact

More information

Online Supplementary Material

Online Supplementary Material Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control

More information

The New England Journal of Medicine. Special Article

The New England Journal of Medicine. Special Article Special Article ASSOCIATION OF THE CALIFORNIA TOBACCO CONTROL PROGRAM WITH DECLINES IN CIGARETTE CONSUMPTION AND MORTALITY FROM HEART DISEASE CAROLINE M. FICHTENBERG, M.S., AND STANTON A. GLANTZ, PH.D.

More information

Mortality in relation to alcohol consumption: a prospective study among male British doctors

Mortality in relation to alcohol consumption: a prospective study among male British doctors IJE vol.34 no.1 International Epidemiological Association 2005; all rights reserved. International Journal of Epidemiology 2005;34:199 204 Advance Access publication 12 January 2005 doi:10.1093/ije/dyh369

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease

More information

Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease

Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease Arch G. Mainous, III, PhD, Charles J. Everett, PhD, Marty S. Player, MD, MS, Dana E. King, MD,

More information

Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS

Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS David M. Burns, Jacqueline M. Major, Thomas G. Shanks INTRODUCTION Smoking norms and behaviors have

More information

First Annual Tobacco Study

First Annual Tobacco Study Maryland Department of Health & Mental Hygiene First Annual Tobacco Study Cigarette Restitution Fund Program Tobacco Use Prevention and Cessation Program September, 2002 Table of Contents Page Executive

More information

Supplementary Online Content

Supplementary Online Content 1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing

More information

CONDITIONAL REGRESSION MODELS TRANSIENT STATE SURVIVAL ANALYSIS

CONDITIONAL REGRESSION MODELS TRANSIENT STATE SURVIVAL ANALYSIS CONDITIONAL REGRESSION MODELS FOR TRANSIENT STATE SURVIVAL ANALYSIS Robert D. Abbott Field Studies Branch National Heart, Lung and Blood Institute National Institutes of Health Raymond J. Carroll Department

More information

Methods in Community-based Intervention Trials Atienza and King Community-based Health Intervention Trials: An Overview of Methodological Issues

Methods in Community-based Intervention Trials Atienza and King Community-based Health Intervention Trials: An Overview of Methodological Issues Epidemiologic Reviews Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 24, No. 1 Printed in U.S.A. Methods in Community-based Intervention Trials Atienza and

More information

A Clinical Study of Plasma Fibrinogen Level in Ischemic Stroke

A Clinical Study of Plasma Fibrinogen Level in Ischemic Stroke Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/24 A Clinical Study of Plasma Fibrinogen Level in Ischemic Stroke Bingi Srinivas 1, B Balaji 2 1 Assistant Professor,

More information

eappendix S1. Studies and participants

eappendix S1. Studies and participants eappendix S1. Studies and participants Eligible population from 11 cohort studies N = 96,211 Excluded: Missing data on exposure or outcome N = 6047 Analytic sample for study of minimally adjusted ERI-

More information

Acute myocardial infarction incidence and hospital mortality: routinely collected national data versus linkage of national registers

Acute myocardial infarction incidence and hospital mortality: routinely collected national data versus linkage of national registers Eur J Epidemiol (2007) 22:755 762 DOI 10.1007/s10654-007-9174-6 CARDIOVASCULAR DISEASE Acute myocardial infarction incidence and hospital mortality: routinely collected national data versus linkage of

More information

Total and Differential Leukocyte Counts as Predictors of Ischemic Heart Disease: The Caerphilly and Speedwell Studies

Total and Differential Leukocyte Counts as Predictors of Ischemic Heart Disease: The Caerphilly and Speedwell Studies American Journal of Epidemiology Copyright 1997 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol 145, No 5 Printed In U SA. A BRIEF ORIGINAL CONTRIBUTION Total

More information

Chapter 3. Producing Data

Chapter 3. Producing Data Chapter 3. Producing Data Introduction Mostly data are collected for a specific purpose of answering certain questions. For example, Is smoking related to lung cancer? Is use of hand-held cell phones associated

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012 SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carotid_intimal_medial_thickness 12/2006 10/2016 10/2018 10/2017 Description of Procedure or Service Ultrasonographic

More information

CARDIOVASCULAR DISEASE EVENT CLASSIFICATION IN THE JACKSON HEART STUDY: METHODS AND PROCEDURES

CARDIOVASCULAR DISEASE EVENT CLASSIFICATION IN THE JACKSON HEART STUDY: METHODS AND PROCEDURES CARDIOVASCULAR DISEASE EVENT CLASSIFICATION IN THE JACKSON HEART STUDY: METHODS AND PROCEDURES Objective: The process of identifying, abstracting, and classifying cardiovascular disease (CVD) endpoints

More information

International model for prevention of chronic disease: Finland experience

International model for prevention of chronic disease: Finland experience International model for prevention of chronic disease: Finland experience Erkki Vartiainen, MD, Professor, Assistant Director General 06/12/2011 Erkki Vartiainen 1 2 Start of the North Karelia project

More information

Mortality from cerebrovascular disease in

Mortality from cerebrovascular disease in 151 Incidence and Outcome of Cerebrovascular Disease in Perth, Western Australia Gary Ward, MBBS, Konrad Jamrozik, MBBS, DPhil, and Edward Stewart-Wynne, FRACP We estimated the event rates for stroke and

More information

The stroke mortality rate in Finland has declined steadily

The stroke mortality rate in Finland has declined steadily Decreased Severity of Brain Infarct Can in Part Explain the Decreasing Case Fatality Rate of Stroke Heikki Numminen, MD; Markku Kaste, MD; Kari Aho, MD; Olli Waltimo, MD; Mervi Kotila, MD Background and

More information

Stroke A Journal of Cerebral Circulation

Stroke A Journal of Cerebral Circulation Stroke A Journal of Cerebral Circulation JULY-AUGUST VOL. 7 1976 NO. 4 Components of Blood Pressure and Risk of Atherothrombotic Brain Infarction: The Framingham Study WILLIAM B. KANNEL, M.D., THOMAS R.

More information

Experimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial

Experimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial Experimental Design Chusak Okascharoen, MD, PhD September 19 th, 2016 Terminology Experimental study Clinical trial Randomized controlled trial 1 PHASES OF CLINICAL TRIALS Phase I: First-time-in-man studies

More information

The Oslo Diet-Heart Study

The Oslo Diet-Heart Study The Oslo -Heart Study Eleven-Year Report By PAUiL LEREN, M.D. SUMMARY The study deals with 412 men, aged 30 to 64 years, randomized 1 to 2 years after a first myocardial infarction. For the experimental

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or biologic

More information